Based in Mississauga, Ontario, SPEC Labs is a not-for-profit organization providing shared, ready-to-use wet lab space for life sciences startups that need room to grow. Their all-inclusive model is designed to remove one of the biggest barriers facing Canadian biotech companies: access to affordable lab infrastructure.

In this episode, host Jim Wilson speaks with founder and CEO Doris Qamar about how a frustrating gap in the Canadian market sparked an idea that took years to bring to life. What started as a search for scalable lab space for a small biotech company became a 20,000 square foot facility in Sheridan Research Park, now open and welcoming its first clients.

Doris also makes a passionate case for why keeping innovation and intellectual property in Canada matters now more than ever.

With the Mississauga location now up and running, SPEC Labs has its sights set on a second location in Toronto in 2028.

Based in Toronto, Ontario, Dr. Kullervo Hynynen is Vice President of Research and Innovation at Sunnybrook Health Sciences Centre and a global leader in focused ultrasound technology. His decades of work have helped transform how the medical community approaches treatment for some of the most challenging neurological and oncological conditions.

In this episode, host Jim Wilson speaks with Dr. Hynynen about a remarkable journey that began on a small farm in rural Finland and led to one of the most significant breakthroughs in modern neuroscience. What started as a rejected NIH grant proposal became the foundation for a technology that can now open the blood-brain barrier non-invasively, potentially unlocking treatment for conditions like Alzheimer's and brain cancer.

Kullervo also reflects on the personal losses that shaped his commitment to cancer research, and how a series of serendipitous career decisions, from Aberdeen to Arizona to Boston to Toronto, brought him to Sunnybrook.

This conversation covers the stubbornness required to push through years of failed experiments, the challenge of commercializing science in Canada, and why Kullervo believes the next frontier is a focused ultrasound helmet that patients could one day use at home.

Based in Toronto, Ontario, Cove Neurosciences is a precision neuroscience company focused on translating complex brain data into meaningful insights. Their analytics software helps researchers and pharmaceutical companies better understand human brain function without requiring specialized data science expertise.

In this episode, host Jim Wilson speaks with co-founder and CEO Dr. Nardin Samuel about the company's unexpected beginnings inside a University of Toronto research lab. What started as a grant application to solve a data analysis problem became the foundation for a commercial software platform now targeting pharmaceutical companies and EEG device manufacturers.

Nardin also opens up about the unique challenge of balancing life as a practicing neurology resident with running a startup, and how the team grew early on through university internship programs.

This conversation covers the realities of the entrepreneurial rollercoaster, the mentorship that shaped Cove's early growth, and why Nardin believes that filtering signal from noise in brain data and in business is the key to staying focused on what matters most.